NIH Advocacy Toolkit for HIV & TB Researchers
The Research Matters Advocacy Toolkit is a vital resource for researchers committed to advancing health equity and biomedical advocacy.
Inside the Fight: A Day in the Life of TAG’s TB Team
What does TAG's work look like in action? Here we step into a day in the life of our TB program co-directors, Mike Frick and Lindsay McKenna, to see how their advocacy for better TB research and policy — made possible by your support — are driving meaningful change to save lives and empower communities affected by TB.
Magic Mountains of Debt: Sovereign Debt Crises as Critical Barriers to Ending TB and Investing in Sustainable Development Goals
TAG’s Magic Mountains of Debt: Sovereign Debt Crises as Critical Barriers to Ending TB and Investing in Sustainable Development Goals analyzes the impact of sovereign debt in depressing investments in TB programs, services, and R&D in high-TB burden nations.
Speed-Up, Scale-Up TB Testing: A Two-Part Webinar Series Focused on the Asia-Pacific Region
TAG, APCASO, and Diagnostics Equity Consortium (DEC) hosted a two-part webinar series exploring the evolving TB diagnostic landscape and strategies to increase TB testing coverage, with a specific focus on the South-East Asia and Western-Pacific regions.
Diagnostics Equity Consortium: Close the Deadly TB Testing Gaps in Asia-Pacific
TAG is one of the endorsers of this Diagnostic Equity Consortium statement and call to action advocating for scaling up access to diagnostics to address the deadly gaps in TB testing.
Scoping Community Interventions to Support New TB Vaccine Introduction: From Grassroots Partnerships to Global Policymaking
Survey now extended until April 24! TAG, with support from Wellcome, is conducting a scoping exercise of community partners and interventions to support new TB vaccine readiness.
LEARN MORE: A Day in the Life of TAG’s TB Team
Learn more about the latest TB vaccine research here: TAG’s TB Vaccines Pipeline Report Learn more about the Global TB CAB here: 10-Year TB CAB Anniversary Evaluation Report and Podcast Learn more about TAG’s work on pre-approval access…
Tuberculosis Research at the National Institutes of Health – Saving Lives, Shrinking Costs, Fueling American Jobs and Innovation
This policy brief describes the crucial role NIH plays in supporting research on new products to prevent, diagnose, and cure TB. This research is especially important at a time when new forms of drug resistance are emerging globally, and rates of TB are rising in the U.S. With continued and increased funding, NIH can protect Americans from the growing threat of TB at home and abroad.
An Activist’s Guide to Shorter Treatment for Drug-Resistant Tuberculosis
The new 2025 update of An Activist’s Guide to Shorter Treatment for Drug-Resistant Tuberculosis lays out what community advocates need to know about WHO-recommended regimens for drug-resistant TB.
Community Materials on Drug-Resistant Tuberculosis
To accompany the updated Activist’s Guide to Shorter Treatment for Drug-Resistant Tuberculosis, TAG also developed three additional educational materials to support community-based and civil society organizations leading treatment literacy, peer support, and community-led monitoring activities: